40 related articles for article (PubMed ID: 33070657)
1. How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions.
Bruger AM; Dorhoi A; Esendagli G; Barczyk-Kahlert K; van der Bruggen P; Lipoldova M; Perecko T; Santibanez J; Saraiva M; Van Ginderachter JA; Brandau S
Cancer Immunol Immunother; 2019 Apr; 68(4):631-644. PubMed ID: 29785656
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the immunosuppressive effects of splenic macrophages in Fischer rats bearing adenocarcinoma 13762.
Bonaventure J; Nigam VN; Brailovsky CA
Cancer Immunol Immunother; 1985; 20(2):167-74. PubMed ID: 3849979
[TBL] [Abstract][Full Text] [Related]
3. Expression and function of VISTA on myeloid cells.
Li S; Wang G; Ren Y; Liu X; Wang Y; Li J; Liu H; Yang J; Xing J; Zhang Y; He C; Xu S; Hou X; Li N
Biochem Pharmacol; 2024 Apr; 222():116100. PubMed ID: 38428824
[TBL] [Abstract][Full Text] [Related]
4. Cellular Export Fate of Liposomal Spherical Nucleic Acids.
Paranandi KS; Lee A; Stanic N; Mirkin CA
ACS Nano; 2023 Oct; 17(19):19000-19010. PubMed ID: 37738539
[TBL] [Abstract][Full Text] [Related]
5. A Regulation Loop between YAP and NR4A1 Balances Cell Proliferation and Apoptosis.
He L; Yuan L; Yu W; Sun Y; Jiang D; Wang X; Feng X; Wang Z; Xu J; Yang R; Zhang W; Feng H; Chen HZ; Zeng YA; Hui L; Wu Q; Zhang Y; Zhang L
Cell Rep; 2020 Oct; 33(3):108284. PubMed ID: 33086070
[TBL] [Abstract][Full Text] [Related]
6. Implications of metabolism-driven myeloid dysfunctions in cancer therapy.
Strauss L; Guarneri V; Gennari A; Sica A
Cell Mol Immunol; 2021 Apr; 18(4):829-841. PubMed ID: 33077904
[TBL] [Abstract][Full Text] [Related]
7. Critical immunosuppressive effect of MDSC‑derived exosomes in the tumor microenvironment.
Rashid MH; Borin TF; Ara R; Piranlioglu R; Achyut BR; Korkaya H; Liu Y; Arbab AS
Oncol Rep; 2021 Mar; 45(3):1171-1181. PubMed ID: 33469683
[TBL] [Abstract][Full Text] [Related]
8. Absence of Anaphylactic Reactions to Injection of Hemoglobin Vesicles (Artificial Red Cells) to Rodents.
Sakai H; Kure T; Kobayashi N; Ito T; Yamada Y; Yamada T; Miyamoto R; Imaizumi T; Ando J; Soga T; Osanai Y; Ogawa M; Shimizu T; Ishida T; Azuma H
ACS Omega; 2024 Jan; 9(1):1904-1915. PubMed ID: 38222647
[TBL] [Abstract][Full Text] [Related]
9. First-in-human phase 1 trial of hemoglobin vesicles as artificial red blood cells developed for use as a transfusion alternative.
Azuma H; Amano T; Kamiyama N; Takehara N; Jingu M; Takagi H; Sugita O; Kobayashi N; Kure T; Shimizu T; Ishida T; Matsumoto M; Sakai H
Blood Adv; 2022 Nov; 6(21):5711-5715. PubMed ID: 35939788
[TBL] [Abstract][Full Text] [Related]
10. Metabolic reprogramming of myeloid-derived suppressor cells: An innovative approach confronting challenges.
Li X; Li Y; Yu Q; Qian P; Huang H; Lin Y
J Leukoc Biol; 2021 Aug; 110(2):257-270. PubMed ID: 34075637
[TBL] [Abstract][Full Text] [Related]
11. B7-H3 Promotes Prostate Cancer Progression in Mice by Antagonizing Myeloid-Derived Suppressor Cell Apoptosis.
Zhou Y; Zhang G; Zhang W; Wei X; Hou J; Huang Y
Technol Cancer Res Treat; 2020; 19():1533033820971649. PubMed ID: 33280506
[TBL] [Abstract][Full Text] [Related]
12. The effect of immunosuppressive drug cyclosporine A on myeloid-derived suppressor cells in transplanted mice.
Han C; Wu T; Na N; Zhao Y; Li W; Zhao Y
Inflamm Res; 2016 Sep; 65(9):679-88. PubMed ID: 27147271
[TBL] [Abstract][Full Text] [Related]
13. Myeloid-derived suppressor cells in transplantation tolerance induction.
Cao P; Sun Z; Feng C; Zhang J; Zhang F; Wang W; Zhao Y
Int Immunopharmacol; 2020 Jun; 83():106421. PubMed ID: 32217462
[TBL] [Abstract][Full Text] [Related]
14. Biocompatibility of HbV: Liposome-Encapsulated Hemoglobin Molecules-Liposome Effects on Immune Function.
Azuma H; Fujihara M; Sakai H
J Funct Biomater; 2017 Jun; 8(3):. PubMed ID: 28657582
[TBL] [Abstract][Full Text] [Related]
15. Contribution of long-chain fatty acid to induction of myeloid-derived suppressor cell (MDSC)-like cells - induction of MDSC by lipid vesicles (liposome).
Yoshida Y; Nagamori T; Ishibazawa E; Kobayashi H; Kure T; Sakai H; Takahashi D; Fujihara M; Azuma H
Immunopharmacol Immunotoxicol; 2020 Dec; 42(6):614-624. PubMed ID: 33070657
[TBL] [Abstract][Full Text] [Related]
16. Liposomal microparticle injection can induce myeloid-derived suppressor cells (MDSC)-like cells in vivo.
Azuma H; Yoshida Y; Takahashi H; Ishibazawa E; Kobayashi H; Sakai H; Takahashi D; Fujihara M
Immunopharmacol Immunotoxicol; 2017 Jun; 39(3):140-147. PubMed ID: 28378599
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
